Search Login Register
trastuzumab
(Herceptin)
Summary
Description:
a HER2 antibody that lengthens remission time in metastatic breast cancer
Also Known As:
Herceptin; Genentech brand of trastuzumab; Hoffman-La Roche brand of trastuzumab; Roche brand of trastuzumab
Networked: 4677
relevant articles (791 outcomes,
1237 trials/studies)
for this Drug
Key Diseases for which trastuzumab is
Relevant
-
Breast Neoplasms (Breast Cancer)
:
523 outcomes 835 studies in 3210 results
-
Neoplasms (Cancer)
:
183 outcomes 285 studies in 1655 results
-
Stomach Neoplasms (Stomach Cancer)
:
62 outcomes 77 studies in 272 results
-
Neoplasm Metastasis (Metastasis)
:
43 outcomes 33 studies in 300 results
-
Carcinoma (Carcinomatosis)
:
26 outcomes 44 studies in 270 results
Show All >>
Drugs Related to trastuzumab
-
trastuzumab (Herceptin)
-
Epidermal Growth Factor Receptor (EGF Receptor)
-
lapatinib (GW572016)
-
docetaxel (Taxotere)
-
Paclitaxel (Taxol)
-
pertuzumab
-
capecitabine (Xeloda)
-
Epidermal Growth Factor (EGF)
-
taxane
-
vinorelbine (Navelbine)
Show All >>
Therapies Related to trastuzumab
-
Drug Therapy (Chemotherapy)
-
Heterologous Transplantation (Xenotransplantation)
-
Adjuvant Chemotherapy
-
Neoadjuvant Therapy
-
Radiotherapy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.